Acute Myeloid Leukemia Coverage From Every Angle
Advertisement
Advertisement

Ann-Kathrin Eisfeld, MD: Why Do Younger Black Patients With AML Have Poor Outcomes?

Posted: Friday, December 4, 2020

Ann-Kathrin Eisfeld, MD, of The Ohio State University Comprehensive Cancer Center, discusses the possible biologic reasons behind SEER data findings showing that Black patients younger than age 60 with acute myeloid leukemia seem to have poor outcomes, regardless of socioeconomic status and access to care.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.